Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outcomes of Pulpotomy Materials in Primary Molars
NCT07120321Completed
- Start
- Jan 2022
- Primary completion
- Jan 2025
- Modality
- Device-based Delivery, Nucleic Acid-Directed Small Molecules, Covalent Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of mineral trioxide aggregate, Biodentine, ferric sulfate and sodium hypochlorite in dental caries and pulpitis (4 arms). Primary endpoint: Number of participants with clinical success after pulpotomy at 12 months. Started Jan 2022; status: completed.
02
Drugs
mineral trioxide aggregateBiodentineferric sulfatesodium hypochlorite
03
Conditions
dental cariespulpitis
Beyond the preview
Go deeper on NCT07120321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07120321.